AI
IDYA icon

Atria Investments’s IDEAYA Biosciences IDYA Stock Holding History

Atria Investments’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$596K Buy
15,993
+1,173
+8% +$35.9K 0.01% 1429
2026
Q1 		$494K Buy
14,820
+862
+6% +$28.9K 0.01% 1455
2025
Q4 		$483K Buy
+13,958
New +$445K 0.01% 1475

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Atria Investments's IDYA Position: Q2 2026 in Review

Atria Investments increased its IDEAYA Biosciences (IDYA) stake by 7.9% in Q2 2026, buying an estimated $35.9K and bringing the position to 15,993 shares worth $596K. The position accounts for 0.01% of the portfolio, ranked #1429.

Atria Investments first reported a position in IDYA in Q4 2025 and has held it in 3 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Atria Investments held 15,993 shares of IDEAYA Biosciences worth $596K as of Q2 2026.
  • Atria Investments bought 1,173 IDEAYA Biosciences shares in Q2 2026, an estimated $35.9K.
  • IDEAYA Biosciences made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1429 holding.
  • Atria Investments first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.